Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix in prostate cancer (BLADE)
NCT03202381Phase 4Unknown
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Jun 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of degarelix in prostate cancer (PCa), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Changes in fat body mass at 12 months. Status: unknown.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03202381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03202381.